Cargando…
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study
BACKGROUND: For locally advanced rectal cancer (LARC) patients who receive neoadjuvant chemoradiotherapy (nCRT), there are no reliable indicators to accurately predict pathological complete response (pCR) before surgery. For patients with clinical complete response (cCR), a “Watch and Wait” (W&W...
Autores principales: | Wang, Yaqi, Yang, Lifeng, Bao, Hua, Fan, Xiaojun, Xia, Fan, Wan, Juefeng, Shen, Lijun, Guan, Yun, Bao, Hairong, Wu, Xue, Xu, Yang, Shao, Yang, Sun, Yiqun, Tong, Tong, Li, Xinxiang, Xu, Ye, Cai, Sanjun, Zhu, Ji, Zhang, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407540/ https://www.ncbi.nlm.nih.gov/pubmed/34464382 http://dx.doi.org/10.1371/journal.pmed.1003741 |
Ejemplares similares
-
Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
por: Wang, Yaqi, et al.
Publicado: (2022) -
Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019) -
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
por: Pezeshki, Parmida Sadat, et al.
Publicado: (2023) -
A novel LARCassigner3 classification predicts outcomes in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: a retrospective training and validation analysis
por: Zhang, Jing, et al.
Publicado: (2019) -
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)
por: Wang, Yaqi, et al.
Publicado: (2022)